Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03061812
Brief Title: Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) (TAHOE)

First Submitted : February 20, 2017
First Submitted that Met QC Criteria : February 20, 2017
First Posted : February 23, 2017

Last Update Submitted that Met QC Criteria : November 27, 2019
Last Update Posted : November 29, 2019